218 related articles for article (PubMed ID: 37700026)
1. Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma.
Chun KH; Park YC; Hwang N; Yoon BK; Kim JW; Fang S
Sci Rep; 2023 Sep; 13(1):15023. PubMed ID: 37700026
[TBL] [Abstract][Full Text] [Related]
2. Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
Coleman S; Xie M; Tarhini AA; Tan AC
Mol Carcinog; 2023 Jan; 62(1):77-89. PubMed ID: 35781709
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis.
Zhang B; Roesner LM; Traidl S; Koeken VACM; Xu CJ; Werfel T; Li Y
Allergy; 2023 Feb; 78(2):439-453. PubMed ID: 35986602
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
Domingo S; Solé C; Moliné T; Ferrer B; Cortés-Hernández J
Cells; 2020 Dec; 9(12):. PubMed ID: 33321931
[TBL] [Abstract][Full Text] [Related]
5. Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures.
Hossain SM; Gimenez G; Stockwell PA; Tsai P; Print CG; Rys J; Cybulska-Stopa B; Ratajska M; Harazin-Lechowska A; Almomani S; Jackson C; Chatterjee A; Eccles MR
Front Immunol; 2022; 13():955063. PubMed ID: 36248850
[TBL] [Abstract][Full Text] [Related]
6. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
[TBL] [Abstract][Full Text] [Related]
7. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
9. Case Report:
Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
Front Immunol; 2021; 12():752563. PubMed ID: 35003064
[TBL] [Abstract][Full Text] [Related]
10. New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Peil J; Bock F; Kiefer F; Schmidt R; Heindl LM; Cursiefen C; Schlereth SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163401
[TBL] [Abstract][Full Text] [Related]
11. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis.
He H; Bissonnette R; Wu J; Diaz A; Saint-Cyr Proulx E; Maari C; Jack C; Louis M; Estrada Y; Krueger JG; Zhang N; Pavel AB; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Jan; 147(1):199-212. PubMed ID: 32709423
[TBL] [Abstract][Full Text] [Related]
12.
Huang Y; Lin A; Gu T; Hou S; Yao J; Luo P; Zhang J
Immunotherapy; 2023 Oct; 15(15):1275-1291. PubMed ID: 37584225
[No Abstract] [Full Text] [Related]
13. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
14. Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment.
Johansson PA; Hayward NK; Pritchard AL
Pigment Cell Melanoma Res; 2023 Mar; 36(2):246-251. PubMed ID: 36617535
[TBL] [Abstract][Full Text] [Related]
15. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
Jiang J; Ding Y; Wu M; Chen Y; Lyu X; Lu J; Wang H; Teng L
Cancer Med; 2020 Nov; 9(22):8498-8518. PubMed ID: 32969604
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
Front Immunol; 2021; 12():758288. PubMed ID: 34804045
[TBL] [Abstract][Full Text] [Related]
18. 9-Gene Signature Correlated With CD8
Yan K; Lu Y; Yan Z; Wang Y
Front Immunol; 2021; 12():622563. PubMed ID: 34220795
[TBL] [Abstract][Full Text] [Related]
19. A fragment of type VI collagen alpha-6 chain is elevated in serum from patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and melanoma.
Holm Nielsen S; Port H; Møller Hausgaard C; Holm JG; Thyssen JP; Groen SS; Karsdal M; Nielsen VW; Egeberg A; Bay-Jensen AC; Thomsen SF
Sci Rep; 2023 Feb; 13(1):3056. PubMed ID: 36810294
[TBL] [Abstract][Full Text] [Related]
20. Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.
Brown LJ; Weppler A; Bhave P; Allayous C; Patrinely JR; Ott P; Sandhu S; Haydon A; Lebbe C; Johnson DB; Long GV; Menzies AA; Carlino MS
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
